Uneingeschränkter Zugang

Functionality evaluation of co-processed excipients as diluents in tablets manufactured by wet granulation


Zitieren

Figure 1

Particle size distribution of LAC (I), LDP (II), SLC (III), MCC (IV), PSV (V), & AVICEL®HFE (VI).
Particle size distribution of LAC (I), LDP (II), SLC (III), MCC (IV), PSV (V), & AVICEL®HFE (VI).

Figure 2

Compressibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.
Compressibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.

Figure 3

Compactibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.
Compactibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.

Figure 4

Tabletability plot of (a) Lactose-based formulations, (b) MCC-based formulations.
Tabletability plot of (a) Lactose-based formulations, (b) MCC-based formulations.

Figure 5

Drug-release profile of Lactose-based formulations.
Drug-release profile of Lactose-based formulations.

Figure 6

Drug-release profile of MCC-based formulations.
Drug-release profile of MCC-based formulations.

Physical properties of metronidazole granules prepared with different diluents.

Formulations with diluents
Parameters I II III IV V VI
Particle size (d50, μm) 290.00 270.00 235.00 165.00 150.00 155.00
Angle of repose (°) 30.03 ± 0.20 29.63 ± 0.50 28.58 ± 1.87 30.25 ± 0.61 27.52 ± 0.32 28.27 ± 0.56
Bulk density (g/cm3) 0.55 ± 0.01 0.54 ± 0.02 0.48 ± 0.01 0.43 ± 0.03 0.43 ± 0.03 0.41 ± 0.01
Tapped density (g/cm3) 0.66 ± 0.02 0.67 ± 0.00 0.60 ± 0.01 0.62 ± 0.07 0.58 ± 0.01 0.56 ± 0.02
True density (g/cm3) 1.46 1.44 1.54 1.52 1.52 1.54
Carr's Index (%) 16.44 ± 0.32 18.86 ± 3.10 19.28 ± 0.33 30.95 ± 3.37 26.51 ± 2.92 25.79 ± 1.83
Hausner's ratio 1.20 ± 0.00 1.23 ± 0.05 1.24 ± 0.01 1.45 ± 0.07 1.36 ± 0.05 1.35 ± 0.03
Moisture content (%) 5.00 5.00 5.00 7.00 9.00 8.00

Physical properties of metronidazole tablets prepared using different diluents.

Formulations with diluents
Parameters I II III IV V VI
Mean weight (mg) 503.10 ± 26.62 507.00 ± 11.41 501.80 ± 13.40 511.90 ± 15.21 509.20 ± 12.84 506.00 ± 9.36
Thickness (mm) 4.02 ± 0.13 4.33 ± 0.06 4.38 ± 0.02 4.02 ± 0.05 4.27 ± 0.06 4.08 ± 0.02
Tensile strength (MPa) 0.78 ± 0.12 0.67 ± 0.30 0.57 ± 0.05 1.19 ± 0.11 0.77 ± 0.04 1.20 ± 0.23
Friability (%) 1.20 1.95 2.00 0.78 1.1 0.69
Disintegration time (min) 14.01 ± 1.57 10.99 ± 1.39 10.96 ± 1.08 25.40 ± 0.34 5.77 ± 2.37 0.32 ± 0.06
T80% (min) 18.00 15.00 14.00 30.00 4.00 35.00

Formula for preparing metronidazole granules and tablets (n = 100 tablets).

Formulations
Ingredients I II III IV V VI
Metronidazole (40%) 20.00 20.00 20.00 20.00 20.00 20.00
Diluent (39%) 19.50 19.50 19.50 19.50 19.50 19.50
Maize starch (10%) 5.00 5.00 5.00 5.00 5.00 5.00
Acacia (10%) 5.00 5.00 5.00 5.00 5.00 5.00
CSD (0.5%) 0.25 0.25 0.25 0.25 0.25 0.25
SSF (0.5%) 0.25 0.25 0.25 0.25 0.25 0.25
Total (g) 50.00 50.00 50.00 50.00 50.00 50.00
eISSN:
2453-6725
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
2 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Pharmazie, andere